This PAR2-centric pathway offers a new perspective on the multifaceted regulation of MMP9, proposing that the local coagulation environment within the tumor contributes to the upregulation of MMP9, thereby enhancing the invasive capabilities of CRC cells (Wu et al., 2013). The gene discussed is F2RL1; the disease is neoplasm.